MedPath

The effect of tDCS on Opioid patients under methadone maintenance treatment

Phase 3
Conditions
Condition 1: Addiction. Condition 2: Addiction.
Opioid abuse with opioid-induced mood disorder
Opioid abuse with opioid-induced sleep disorder
F11.14
F11.182
Registration Number
IRCT20180604039979N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Detection of drug abuse and dependence on opioids under methadone maintenance treatment according to DSM-V diagnostic criteria by a specialist psychiatrist
The patient only receives methadone treatment
Methadone maintenance treatment for at least one year
Have at least 9th grade literacy
Complete informed consent
Aged 18-60 years

Exclusion Criteria

Having any progressive disease, such as diabetes and neurological diseases, especially a history of head truma and seizure
Having metal objects or prostheses in head
Having a shunt on the skull and pacemaker in the heart
The presence of severe psychiatric illnesses in the I axis based on DSM-V diagnostic criteria: such as psychotic disorders
Taking other medicines in addition to methadone (such as morphine, hashish, glass)
Unwilling to participate in research

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduce craving. Timepoint: Fourth and seventh session of intervention. Method of measurement: desire for drug questionnaire(DDQ).;Reduce relaps. Timepoint: Fourth and seventh session of intervention. Method of measurement: Urine test.;Reduce depression. Timepoint: Fourth and seventh session of intervention. Method of measurement: Depression, Anxiety and stress Scales (DASS-21).;Reduce anxiety. Timepoint: Fourth and seventh session of intervention. Method of measurement: Depression, Anxiety and stress Scales(DASS-21).;Reducing stress. Timepoint: Fourth and seventh session of intervention. Method of measurement: Depression, Anxiety and stress Scales(DASS-21).;Sleep quality. Timepoint: Fourth and seventh session of intervention. Method of measurement: Pittsburgh Sleep Quality Index(PSQI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath